Test Price
2,800 AED✅ Home Collection Available
NPC1 Gene (Niemann‑Pick Type C1) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين NPC1 لمرض نيمان-بيك نوع C1 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑certified NGS processing.
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
Insurance & Billing: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي: اختبار وراثي عالي الدقة لتشخيص مرض نيمان-بيك النوع C1 عبر تقنية التسلسل الجيني الشامل (NGS) لتحليل طفرات جين NPC1. معتمد من هيئة الصحة بدبي وبنظام إدارة الجودة ISO 9001:2015، يضمن نتائج دقيقة بنسبة 99.9% مع دعم استشاري متكامل.
1. Overview
The NPC1 Gene NGS Test analyses the entire coding region of NPC1 to detect pathogenic variants causing Niemann‑Pick disease type C1, a progressive neurodegenerative lysosomal storage disorder. (تحليل جين NPC1 لتشخيص مرض نيمان-بيك التنكسي العصبي). Results guide neurologists, medical geneticists, and pediatricians in confirming diagnosis, carrier screening, and family planning.
| Feature | Our NPC1 NGS Test | Closest Alternative (e.g., Biochemical Assay) |
|---|---|---|
| Precision | Full gene sequencing with >99.9% sensitivity for SNVs, indels, CNVs | Indirect enzyme activity or filipin staining – lower specificity, may miss atypical forms |
| Methodology | Next‑Generation Sequencing (NGS) with MLPA confirmation | Sanger sequencing (limited to known hotspots) or enzymatic assay |
| Turnaround Time | 3–4 Weeks | 4–8 Weeks (biochemical testing often requires cultured fibroblasts) |
| Clinical Utility | Definitive molecular diagnosis, carrier status, prenatal/preimplantation options | Screening only; may require genetic confirmation for final diagnosis |
2. Physician Insight & Safety Protocol
“A positive NPC1 genetic result is a starting point—clinical correlation with neurological examination, imaging, and biomarker studies is essential. My team is here to guide you through every step, ensuring that the genomic data translates into timely, compassionate care.”
— Dr. Prabhakar Reddy, DHA‑Licensed Consultant (ID: 61713011)
⚠ Medication Warning & Safety Exclusion
Do not discontinue prescribed medication without consulting your doctor. Genetic testing does not replace ongoing neurological management.
- Exclusion Criteria: Patients with severe coagulopathy or inability to provide a blood/DNA sample. Paediatric patients require pediatrician & genetic counsellor clearance.
- Emergency Red Flags: If the individual experiences sudden neurological deterioration (e.g., loss of consciousness, seizures, inability to swallow), proceed to the nearest emergency department immediately—do not wait for test results.
- Minor Consent: Strictly adheres to UAE CDS Law 2026 – mandatory parental/guardian informed consent for all minors.
All genetic data is protected under UAE PDPL. Test conducted under MOHAP/DHA license #9834453, ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
3. Patient FAQ & Clinical Guidance
❓ What does the NPC1 gene NGS test diagnose?
This test identifies pathogenic variants in the NPC1 gene to confirm Niemann‑Pick disease type C1, a severe neurovisceral disorder, with complete sequencing coverage that enables definitive diagnosis and family risk assessment.
س: ماذا يشخص تحليل جين NPC1 بتقنية NGS؟ ج: يحدد هذا الاختبار الطفرات المرضية في جين NPC1 لتأكيد مرض نيمان-بيك نوع C1 العصبي الحشوي الوراثي بدقة عالية، مما يتيح تشخيصاً قاطعاً وتقدير المخاطر العائلية.
❓ How should I prepare for the NPC1 test?
No fasting or medication adjustments are required for blood/DNA collection, but you must complete a pre‑test genetic counselling session to document family history and sign informed consent.
س: كيف أستعد لاختبار NPC1؟ ج: لا حاجة للصيام أو تغيير الأدوية، ولكن يشترط حضور جلسة استشارة وراثية قبل الفحص لتوثيق التاريخ العائلي وتوقيع الموافقة المستنيرة.
❓ Can this test be used for prenatal diagnosis or carrier screening?
Yes, once a familial mutation is known, we can perform prenatal testing or assess carrier status for relatives; the provides actionable information for reproductive planning and early intervention.
س: هل يصلح الاختبار لتشخيص ما قبل الولادة أو فحص حاملي المرض؟ ج: نعم، بعد تحديد الطفرة العائلية، يمكن إجراء فحص السائل الأمينوسي أو تحليل الحامل للأقارب، مما يوفّر معلومات حاسمة للتخطيط الإنجابي والتدخل المبكر.
4. Regulatory & Data Privacy
Our laboratory operates under Federal Decree-Law No. 41 of 2024 (Art. 87) governing genetic testing and personal health data, and the UAE Clinical Data Standards (CDS) Law 2026 for minor consent. All personally identifiable genetic information is processed in compliance with the UAE Personal Data Protection Law (PDPL). ISO 9001:2015 certification ensures quality management from sample collection to report delivery.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians